Figure (Lev21 0000 01)
Levetiracetam Injection, Solution
Product Images NDC 25021-795
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 25021-795). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Lev21 0000 02)
This text includes various percentage values, possibly related to a study or experiment. It mentions the comparison between Placebo, Levetiracetam, and Lovotiracatam at different doses. Additionally, it indicates that one of the comparisons is statistically significant versus the placebo.*
Figure 2 (Lev21 0000 03)
This text provides a statistical summary of different percentages related to patients in a study comparing a placebo group with two different doses of Levetiracetam (1000 mg/day and 2000 mg/day). Data suggests that certain results were statistically significant.*
Figure 3 (Lev21 0000 04)
Figure 4 (Lev21 0000 05)
Package Label – Principal Display Panel – Bag Label (Lev21 0000 06)
This is a description of a medication labeled as Levetiracetam in 0.82% Sodium Chloride Injection. Each 100 mL contains 500 mg of Levetiracetam, with a concentration of 5 mg per mL. It is meant for intravenous infusion only and must be infused over a period of 15 minutes. The medication also includes sodium chloride, placial acetic acid, and buffered trtinehydrate. It is advised not to dilute the solution further before use and to use the unit promptly once the overwrap is removed. Storage recommendations include keeping it between 20°C to 25°C (68°F to 77°F) in a controlled room temperature environment. The text also mentions not to use plastic containers in series connections.*
Package Label – Principal Display Panel – Bag Label (Lev21 0000 07)
This text provides details about a medication labeled as NDC 25021-794-82, Levetiracetam in 0.75% Sodium Chloride Injection with a concentration of 1,000 mg per 100 mL. It is meant for intravenous infusion only and should be administered over a 15-minute period. The solution contains Levetiracetam, sodium chloride, glacial acetic acid, sodium acetate trihydrate, and water for injection. The usual dosage instructions can be found in the package insert. It is advised not to dilute the solution further before use and not to use plastic containers in series connections. The recommended storage temperature is 20°C to 25°C (68°F to 77°F).*
Package Label – Principal Display Panel – Bag Label (Lev21 0000 08)
Description: NDC 25021-795-82 is a 100 mL solution of Levetiracetam in 0.54% Sodium Chloride Injection with a concentration of 1,500 mg per 100 mL (15 mg per mL). This solution is for Intravenous Infusion Only and should be infused over a period of 15 minutes. The formulation also contains water for injection, sodium chloride, glacial acetic acid, and sodium acetate. It is important not to dilute the solution further or use containers in series connections. Storage recommendation is at 20°C to 25°C (68°F to 77°F) and the solution comes in a single-dose dual port bag from SAGENT®. Please refer to the package insert for the usual dosage.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
